he controversies underlying the debates concerning pre-PMF, which had been included in the 2001 World Health Organization (WHO) myeloid classification scheme as “chronic idiopathic myelofibrosis pre-fibrotic stage” (Jaffe et al, 2001), derive from multiple reasons that will be briefly discussed in this article.
Comments on pre-fibrotic myelofibrosis and how should it be managed / Barbui T.; Thiele J.; Gisslinger H.; Orazi A.; Vannucchi A.M.; Gianelli U.; Beham-Schmid C.; Tefferi A.. - In: BRITISH JOURNAL OF HAEMATOLOGY. - ISSN 0007-1048. - ELETTRONICO. - 186:(2019), pp. 358-360. [10.1111/bjh.15840]
Comments on pre-fibrotic myelofibrosis and how should it be managed
Vannucchi A. M.;
2019
Abstract
he controversies underlying the debates concerning pre-PMF, which had been included in the 2001 World Health Organization (WHO) myeloid classification scheme as “chronic idiopathic myelofibrosis pre-fibrotic stage” (Jaffe et al, 2001), derive from multiple reasons that will be briefly discussed in this article.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Barbui2.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
104.07 kB
Formato
Adobe PDF
|
104.07 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
